In addition, the decline in the ASIR of prostate cancer in the study period was also supposed to be a so-called “backlog” after initial detection of prevalent prostate cancer that had accumulated as a result of incidence in previous years after initiation of PSA screening. This evidence concerns the gene KLK3 and prostate cancer.